70171-70-9 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule of the compound.
2. Urea derivative
Explanation
A urea derivative is a compound that contains a urea group (NH2-C(=O)-NH-) as part of its structure.
3. Phenol ring
Explanation
The phenol ring is a six-membered aromatic ring with a hydroxyl group (-OH) attached to it.
4. Propan-2-yl group
Explanation
A propan-2-yl group is a three-carbon alkyl group (-CH(CH3)2) attached to the nitrogen atom of the urea group.
5. Potential applications in pharmaceuticals
Explanation
The compound may have properties that make it useful in the development of new drugs or drug formulations.
6. Organic synthesis
Explanation
The compound can be used as a building block or intermediate in the synthesis of other organic compounds.
7. Medical research
Explanation
Further investigation and study of the compound may reveal its potential benefits and applications in various fields of medical research.
8. Structure
Explanation
The compound consists of a urea group attached to a phenol ring, with a propan-2-yl group attached to the nitrogen atom of the urea group.
9. Chemical properties
Explanation
The compound's chemical properties, such as reactivity, solubility, and stability, may be influenced by its molecular structure and functional groups.
10. Physical properties
Explanation
The compound's physical properties, such as melting point, boiling point, and density, may be relevant to its potential applications and handling.
Check Digit Verification of cas no
The CAS Registry Mumber 70171-70-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,1,7 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 70171-70:
(7*7)+(6*0)+(5*1)+(4*7)+(3*1)+(2*7)+(1*0)=99
99 % 10 = 9
So 70171-70-9 is a valid CAS Registry Number.
70171-70-9Relevant articles and documents
Synthesis and antitumor activity of novel pyridino[2,3-d]pyrimidine urea derivatives
Chen, Dongmei,Chen, Yumei,Yang, Di,Zheng, Zhaopeng,Zhou, Zhixu
, p. 1628 - 1636 (2021/05/19)
A series of novel N-(3-((6-bromopyrido[2,3-d]pyrimidin-4-yl)oxy)phenyl)pyrrolidine-1-carboxamide and 1-(3-((6-bromopyrido[2,3-d]pyrimidin-4-yl)oxy)phenyl)-3-propylurea derivatives were synthesized. Their antitumor activities against human breast carcinoma cells (MCF-7) and human colon cancer cells (HCT-116) in vitro were evaluated, using sorafenib as a positive control drug. Anticancer bioassays indicated that several compounds exhibited appreciable anticancer activity against MCF-7 and HCT-116 cells. Particularly, compounds 9g and 8b demonstrated the most significant inhibitory effect against HCT-116 and MCF-7 cells, with inhibition ratios of 25.56% and 26.46%, respectively. Additionally, the synthesized pyridine[2,3-d]pyrimidine derivatives containing a urea group moieties exhibited antitumor activities against MCF-7 and HCT-116 cells in vitro.